Traditionally small molecules have mainly been used to inhibit biochemical activities of proteins, however such compounds can also be used to change the conformational energy landscape of proteins. Tool compounds that modulate protein conformations often reveal unexpected biological mechanisms, which have therapeutic potential. We discuss two examples where screening hits were found to bind to unexpected binding pockets on well known proteins, establishing new routes for the inhibition of proteins that were thought to be undruggable.
Keywords: (E)-3-fluoro-N'-((5-(pyrimidin-2-ylthio)furan-2-yl)methylene) benzohydrazide (PubChem CID: 76554134); 2-chloro-1-[2-[3-(trifluoromethyl)anilino]phenyl]ethanone (PubChem CID: 137796964); Allosteric inhibitors; Chemical biology; Drug discovery; Flufenamic acid (PubChem CID: 3371); Iodoacetamide (PubChem CID: 3727); Structural biology.
Copyright © 2020 Elsevier Ltd. All rights reserved.